These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 33680863)

  • 21. [Alcoholic liver disease].
    Chae HB
    Korean J Gastroenterol; 2009 May; 53(5):275-82. PubMed ID: 19458463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stearic acid prevent alcohol-induced liver damage by regulating the gut microbiota.
    Nie W; Xu F; Zhou K; Yang X; Zhou H; Xu B
    Food Res Int; 2022 May; 155():111095. PubMed ID: 35400467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and Management of Alcoholic Liver Disease.
    Dugum M; McCullough A
    J Clin Transl Hepatol; 2015 Jun; 3(2):109-16. PubMed ID: 26356792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress and redox signaling mechanisms of alcoholic liver disease: updated experimental and clinical evidence.
    Zhu H; Jia Z; Misra H; Li YR
    J Dig Dis; 2012 Mar; 13(3):133-142. PubMed ID: 22356308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probiotic and glutamine treatments attenuate alcoholic liver disease in a rat model.
    Huang H; Lin Z; Zeng Y; Lin X; Zhang Y
    Exp Ther Med; 2019 Dec; 18(6):4733-4739. PubMed ID: 31777560
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Luo P; Zheng M; Zhang R; Zhang H; Liu Y; Li W; Sun X; Yu Q; Tipoe GL; Xiao J
    Acta Pharm Sin B; 2021 Mar; 11(3):668-679. PubMed ID: 33777674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acrolein Is a Pathogenic Mediator of Alcoholic Liver Disease and the Scavenger Hydralazine Is Protective in Mice.
    Chen WY; Zhang J; Ghare S; Barve S; McClain C; Joshi-Barve S
    Cell Mol Gastroenterol Hepatol; 2016 Sep; 2(5):685-700. PubMed ID: 28119953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcomes in patients with decompensated alcohol-related liver disease, steatohepatitis and Maddrey's discriminant function <32.
    Degré D; Stauber RE; Englebert G; Sarocchi F; Verset L; Rainer F; Spindelboeck W; Njimi H; Trépo E; Gustot T; Lackner C; Deltenre P; Moreno C
    J Hepatol; 2020 Apr; 72(4):636-642. PubMed ID: 31954208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutathione and antioxidant enzymes serve complementary roles in protecting activated hepatic stellate cells against hydrogen peroxide-induced cell death.
    Dunning S; Ur Rehman A; Tiebosch MH; Hannivoort RA; Haijer FW; Woudenberg J; van den Heuvel FA; Buist-Homan M; Faber KN; Moshage H
    Biochim Biophys Acta; 2013 Dec; 1832(12):2027-34. PubMed ID: 23871839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern recognition receptor CD14 gene polymorphisms in alcohol use disorder patients and its Influence on liver disease susceptibility.
    Roy N; Nadda N; Kumar H; Prasad C; Kumar Jha J; Pandey HC; Vanamail P; Saraya A; Balhara YPS; Shalimar ; Nayak B
    Front Immunol; 2022; 13():975027. PubMed ID: 36238273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatoprotective Effect of Oyster Peptide on Alcohol-Induced Liver Disease in Mice.
    Wang X; Yu H; Xing R; Li P
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids.
    Way GW; Jackson KG; Muscu SR; Zhou H
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decoding cell death signals in liver inflammation.
    Brenner C; Galluzzi L; Kepp O; Kroemer G
    J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prognostic evaluation and management of alcoholic hepatitis.
    Rana R; Wang SL; Li J; Xia L; Song MY; Yang CQ
    Minerva Med; 2017 Dec; 108(6):554-567. PubMed ID: 28602070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication.
    Israelsen M; Kim M; Suvitaival T; Madsen BS; Hansen CD; Torp N; Trost K; Thiele M; Hansen T; Legido-Quigley C; Krag A;
    JHEP Rep; 2021 Oct; 3(5):100325. PubMed ID: 34401690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver transplantation and alcoholic liver disease: History, controversies, and considerations.
    Marroni CA; Fleck AM; Fernandes SA; Galant LH; Mucenic M; de Mattos Meine MH; Mariante-Neto G; Brandão ABM
    World J Gastroenterol; 2018 Jul; 24(26):2785-2805. PubMed ID: 30018475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut Microbiome and Alcohol-associated Liver Disease.
    Philips CA; Schnabl B; Bajaj JS
    J Clin Exp Hepatol; 2022; 12(5):1349-1359. PubMed ID: 36157139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current Management and Future Treatment of Alcoholic Hepatitis.
    Mitchell MC; Kerr T; Herlong HF
    Gastroenterol Hepatol (N Y); 2020 Apr; 16(4):178-189. PubMed ID: 34035720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telmisartan alleviates alcohol-induced liver injury by activation of PPAR-γ/ Nrf-2 crosstalk in mice.
    Abdelhamid AM; Elsheakh AR; Suddek GM; Abdelaziz RR
    Int Immunopharmacol; 2021 Oct; 99():107963. PubMed ID: 34273638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.